Visualitza per autor "Morales, Serafin"
Ara mostrant els elements 1-3 d 3
-
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer
Cescon, David; Hilton, John; Morales, Serafin; Layman, Rachel; Pluard, Timothy; Yeo, Belinda; Oliveira, Mafalda (American Association for Cancer Research, 2024-01-15) -
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
Quintela-Fandino, Miguel; Holgado, Esther; Manso, Luis; Bermejo, Begoña; Colomer, Ramon; Cortés Castan, Javier; Morales, Serafin (BMC, 2020-11-11) -
Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study
Gil-Gil, Miguel J.; Bergamino, Milana; Barnadas, Agustí; Manso, Luis; Bellet Ezquerra, Meritxell; Saura Manich, Cristina; Morales, Serafin (Frontiers Media, 2021-07)